Bank of New York Mellon’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.9M | Sell |
|
|||||
|
2025
Q2 | $47.6M | Sell |
|
|||||
|
2025
Q1 | $45.5M | Sell |
|
|||||
|
2024
Q4 | $38.1M | Sell |
|
|||||
|
2024
Q3 | $42.9M | Sell |
|
|||||
|
2024
Q2 | $40.4M | Buy |
|
|||||
|
2024
Q1 | $43.9M | Sell |
|
|||||
|
2023
Q4 | $44.5M | Sell |
|
|||||
|
2023
Q3 | $44.5M | Sell |
|
|||||
|
2023
Q2 | $50.5M | Sell |
|
|||||
|
2023
Q1 | $61.8M | Sell |
|
|||||
|
2022
Q4 | $70M | Buy |
|
|||||
|
2022
Q3 | $66.8M | Buy |
|
|||||
|
2022
Q2 | $58.4M | Buy |
|
|||||
|
2022
Q1 | $46.9M | Sell |
|
|||||
|
2021
Q4 | $53.7M | Sell |
|
|||||
|
2021
Q3 | $61.5M | Buy |
|
|||||
|
2021
Q2 | $40.7M | Buy |
|
|||||
|
2021
Q1 | $37.2M | Buy |
|
|||||
|
2020
Q4 | $23.7M | Buy |
|
|||||
|
2020
Q3 | $10.8M | Buy |
|
|||||
|
2020
Q2 | $2.49M | Buy |
|